Ahluwalia, M. S., Reardon, D. A., Butowski, N. A., Aiken, R., Peereboom, D. M., Venur, V., Abad, A. P., Belal, A., Casucci, D. M., Figel, S. A., Odia, Y., Chen, Z., Sinicrope, K., Boockvar, J. A., Barbaro, M., Brenner, A. J., Vaillant, B. D., Fenstermaker, R. A., Ciesielski, M. J., Qiu, J. (2026). Prospective, randomized, placebo-controlled phase 2b trial of SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma (SURVIVE).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2106